MWNA
COCH icon

Marshall Wace North America’s Envoy Medical COCH Stock Holding History

Marshall Wace North America’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2.42M Hold
249,999
– – 0.01% 681
2021
Q2 		$2.42M Buy
+249,999
New +$2.43M 0.01% 750

Other funds holding COCH

Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
DAM
DLD Asset Management New York $1.51B AUM 5.32% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Marshall Wace North America's COCH Position: Q3 2021 in Review

Marshall Wace North America held its Envoy Medical (COCH) position steady in Q3 2021 at 249,999 shares worth $2.42M. The position accounts for 0.01% of the portfolio, ranked #681.

Marshall Wace North America first reported a position in COCH in Q2 2021 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold COCH as of Q3 2021.

  • Marshall Wace North America held 249,999 shares of Envoy Medical worth $2.42M as of Q3 2021.
  • Marshall Wace North America left its Envoy Medical share count unchanged in Q3 2021.
  • Envoy Medical made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #681 holding.
  • Marshall Wace North America first reported a position in Envoy Medical in Q2 2021 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.